Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants, By End-users, By Applications, By Distribution Channels By Region

Description

Intramuscular Vaccine Adjuvants Market is estimated to be valued at USD 790.8 Mn in 2025 and is expected to reach USD 1,245.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 790.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.70%	2032 Value Projection:	USD 1,245.1 Mn

Vaccines are considered as one of the most effective methods for the prevention and control of infectious diseases. This is primarily due to their ability to target specific pathogens and stimulate the immune system. Moreover, these products are also inexpensive and can be used to treat multiple diseases simultaneously.

Market Dynamics:

The global intramuscular vaccine adjuvants market is expected to experience substantial growth during the forecast period due to several factors. These include an increased demand for safe and effective vaccines, the ongoing pace of innovation in this field, and financial support from various private and public sector investors. A growing geriatric population coupled with increasing prevalence of chronic diseases are other major drivers fuelling growth of the global vaccine adjuvants market. Moreover, the presence of large numbers of hospitals and other healthcare facilities is also expected to propel market growth during the forecast period. In addition, the emergence of novel therapeutics is further expected to boost market growth.

On the other hand, side-effects and toxicity of adjuvants is expected to hinder the market growth.

Key features of the study:

This report provides in-depth analysis of the global intramuscular vaccine adjuvants market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global intramuscular vaccine adjuvants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novavax, Inc., Adjuvance Technologies, Inc., Invivogen, Vaxine Pty Ltd., SEPPIC, SPI Pharma, Inc., Agenus Inc., Avanti Polar Lipids, Inc., CSL Limited, and OZ Biosciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global intramuscular vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global intramuscular vaccine adjuvants market

Detailed Segmentation:

Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants:
- Oil-based Adjuvants
- Liposome-based Adjuvants
- Polymer-based Adjuvants
- Mineral-based Adjuvants
- Others
Global Intramuscular Vaccine Adjuvants Market, By End Users:
- Pediatrics
- Adults
- Geriatrics
Global Intramuscular Vaccine Adjuvants Market, By Applications:
- Infectious diseases
- Cancer
- Others
Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels:
- Hospitals
- Clinics
- Research Centers
Global Intramuscular Vaccine Adjuvants Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Novavax, Inc.
- Adjuvance Technologies, Inc.
- Invivogen
- Vaxine Pty Ltd.
- SEPPIC
- SPI Pharma, Inc.
- Agenus Inc.
- Avanti Polar Lipids, Inc.
- CSL Limited
- OZ Biosciences

Product Code: CMI5650

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Intramuscular Vaccine Adjuvants, By Type of Adjuvants
- Market Intramuscular Vaccine Adjuvants, By End users
- Market Intramuscular Vaccine Adjuvants, By Applications
- Market Intramuscular Vaccine Adjuvants, By Distribution Channels
- Market Intramuscular Vaccine Adjuvants, By Region
Coherent Opportunity Map (COM)

3. Global Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Growing geriatric population coupled with increasing prevalence of chronic diseases
- Increased government vaccination recommendations
- Restraints
- Side-effects and toxicity of adjuvants
- Opportunities
- Increased research and development activities in this field
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Intramuscular Vaccine Adjuvants Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Intramuscular Vaccine Adjuvants Market , By Type of Adjuvants, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2025 - 2032
- Segment Trends
Oil-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Liposome-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Liposome-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Mineral-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Intramuscular Vaccine Adjuvants Market, By End Users, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2025 - 2032
- Segment Trends
Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Geriatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Global Intramuscular Vaccine Adjuvants Market, By Applications, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2025 - 2032
- Segment Trends
Infectious diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2025 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

9. Global Intramuscular Vaccine Adjuvants Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2025 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2020-2032,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2020-2032,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2020-2032,(US$ Mn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2020-2032,(US$ Mn)

10. Competitive Landscape

Novavax, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Adjuvance Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invivogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Vaxine Pty Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SEPPIC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SPI Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agenus Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Avanti Polar Lipids, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
OZ Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views

11. Section

Research Methodology
About us